Astrana Health (ASTH) Expected to Announce Earnings on Thursday

Astrana Health (NASDAQ:ASTH) is expected to release its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Astrana Health to post earnings of $0.49 per share and revenue of $952.83 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, November 6, 2025 at 5:30 PM ET.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Wednesday, January 10th. The company reported $0.50 EPS for the quarter. The business had revenue of $317.00 million for the quarter. Astrana Health had a return on equity of 3.43% and a net margin of 1.04%. On average, analysts expect Astrana Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Astrana Health Stock Performance

Shares of Astrana Health stock opened at $33.10 on Wednesday. The business’s fifty day simple moving average is $30.49 and its 200 day simple moving average is $27.88. The firm has a market capitalization of $1.86 billion, a P/E ratio of 64.90, a price-to-earnings-growth ratio of 0.90 and a beta of 0.80. Astrana Health has a 12 month low of $21.20 and a 12 month high of $60.99. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ASTH shares. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a report on Friday, October 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astrana Health in a report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $47.40.

Hedge Funds Weigh In On Astrana Health

Several hedge funds have recently made changes to their positions in the stock. State of Wyoming purchased a new position in shares of Astrana Health in the second quarter valued at $132,000. Caxton Associates LLP purchased a new position in shares of Astrana Health in the second quarter valued at $534,000. Public Sector Pension Investment Board grew its position in shares of Astrana Health by 7.4% in the second quarter. Public Sector Pension Investment Board now owns 141,541 shares of the company’s stock valued at $3,522,000 after purchasing an additional 9,730 shares in the last quarter. Tower Research Capital LLC TRC grew its position in shares of Astrana Health by 323.3% in the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock valued at $115,000 after purchasing an additional 3,517 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its position in shares of Astrana Health by 797.1% in the second quarter. BNP Paribas Financial Markets now owns 27,630 shares of the company’s stock valued at $687,000 after purchasing an additional 24,550 shares in the last quarter. 52.77% of the stock is currently owned by hedge funds and other institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.